SCHEMBL24309772

SCHEMBL24309772

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2ccc(C3CCN(C)CC3)cc2)c1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 6/20 0.35
▸ HTR7 P34969 6/20 0.35
▸ BRD4 O60885 2/20 0.34
▸ SLC8A1 P32418 1/20 0.33
▸ BRAF P15056 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ PTK2 Q05397 4/20 0.33
▸ SCN9A Q15858 3/20 0.33
▸ FLT4 P35916 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ PCK1 P35558 1/20 0.32
▸ CCNT1 O60563 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CCND3 P30281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26812416 0.95 BRD4 (0.35) HTR1AHTR7BRD4SLC8A1BRAF
SCHEMBL29567305 0.95 BRD4 (0.35) HTR1AHTR7BRD4SLC8A1BRAF
SCHEMBL26808599 0.94 BRD4 (0.35) HTR1AHTR7BRD4SLC8A1BRAF
SCHEMBL24309541 0.94 HTR1A (0.34) HTR1AHTR7BRD4SLC8A1BRAF
SCHEMBL24310811 0.93 HTR1A (0.36) HTR1AHTR7BRD4SLC8A1PTK2
SCHEMBL29566898 0.93 HTR1A (0.36) HTR1AHTR7BRD4SLC8A1PTK2
SCHEMBL26808596 0.93 HTR1A (0.36) HTR1AHTR7SLC8A1BRAFKDR
SCHEMBL26808563 0.92 BRD4 (0.34) HTR1AHTR7BRD4BRAFKDR
SCHEMBL26808566 0.92 SCN9A (0.36) HTR1AHTR7BRD4SLC8A1BRAF
SCHEMBL26808605 0.92 HTR1A (0.34) HTR1AHTR7BRD4SLC8A1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback